Limits on Playing the STOLI Card: A Carrier’s Duty to Investigate Fraud

Crafted as a legislative compromise between two competing interests, the contestability
period for life insurance policies provides a two year window after issuance of a policy, during
which a carrier may continue its due diligence review of an insured and matters relating to
policy origination.

Read the Investors Note




ILMA Welcomes Wilmington Trust as Allied Member

Becomes Tenth Allied Member to Growing Trade Association

WASHINGTON, D.C. – The Institutional Life Markets Association (ILMA) is pleased to welcome Wilmington Trust to the not-for-profit trade association as an Allied Member.

Read the press release

ILMA Amicus Brief on Cabal Case

A husband purchased a life insurance policy through a trust. The husband designated his wife as the beneficiary of the trust, making her the ultimate beneficiary of the policy. Three months after the policy was issued, the wife sold
her interest in the trust to a third party.

Read the Amicus Brief


Insurable Interest after Price Dawe, Schlanger and Brasner

Recent decisions from courts in Florida and
Delaware have garnered significant attention and
refocused the life settlement industry on the issue
of insurable interest and policy origination practices.

Read the Investors Note


ILMA Continues to Expand Membership

Board Approves New Charter Member and Allied Member

WASHINGTON, D.C. – The Institutional Life Markets Association (ILMA) announces the expansion of their membership with the Board of Directors voting recently to accept Fortress Investment Group and Examination Management Services, Inc. (EMSI) to the not-for-profit trade association.

Read the Press Release



Trends in Cost of Insurance

A life settlement is based on one fundamental item, a life insurance contract. Absent fraud, contractual limitations or carrier default, the certainty that the net death benefit will be paid out is not a matter of if, but when. Given a large and diversified pool of life settlements, an investor should be able to create a relatively predictable and low volatility return.

Read the Investors Note

ILMA Releases Investors Note on Courth of Appeals Ruling

Teren Case Ruling May Have Implications for Many Pending Cases across Country

WASHINGTON, D.C. – The Institutional Life Markets Association (ILMA) today released their latest Investors Note entitled “Form over Intent: Understanding the Jack Teren Insurable Interest Case.”

Read the Press Release
Read the Investors Note

ILMA Welcomes Two New Allied Members

Vida Capital and Silver Point Capital Join Leading Life Markets Institutional Investors

WASHINGTON, D.C. – The Institutional Life Markets Association (ILMA) today welcomed Vida Capital and Silver Point Capital as “Allied Members” of the not-for-profit trade association.

Read the Press Release

 

As the Dust Settles in the Life Settlement Industry: A Review of Major Legal Decisions in 2010 and What's in Store for 2011

ILMA looks at several key decisions issued in 2010 and discusses what the future may hold.

Read the Investors Note

 

Life Settlement Provider Best Practices

The Institutional Life Markets Association (ILMA) released the “Life Settlement Provider Best Practices”, a guide of minimum compliance and diligence procedures for life settlement providers.

The full version of ILMA’s “Life Settlement Provider Best Practices” is available here.

Read the press release.

 

202-552-2788       info@lifemarketsassociation.org

 
 

 

LifeHealthPro
Obama Tax Plan Draws Bead on Insurers

FT Adviser
FSA launches probe into ARM distributor

Corpus Christi Caller Times
State securities board fines two Corpus Christi investment adviser representatives

S. Securities and Exchange Commission
SEC Charges Life Settlements Firm and Three Executives with Disclosure and Accounting Fraud - CEO and General Counsel Additionally Charged With Insider Trading

Calgary Herald (Canada)
Bosses of insurance policy investment firm accused of Ponzi fraud; dozens of Albertans affected

New Model Adviser (Citywire)
The dangers of the FSA's tough new approach to products

FT Adviser
FSA's stance on life settlements under scrutiny

Money Marketing
What next after life settlements? - the dangers of blanket bans

Read other News You Can Use articles

 

What is ILMA?

ILMA is a not-for profit trade association focused on the longevity and mortality-related marketplace. By creating innovative capital market solutions, ILMA members seek to expand consumer choice in one of their most important assets - their life insurance. The Association is a leader in establishing best practices and in raising awareness about this growing and vital industry.

ILMA's mission is to expand and apply capital market solutions in life insurance, educate consumers that their insurance may be a valuable asset, expand consumer choices about how to manage it, and support the responsible growth and regulation of the industry. We believe that expanded consumer choice and full disclosure of all fees is good for the consumer and for the industry.

ILMA's founding members include Credit Suisse, Mizuho International plc, Goldman, Sachs & Co, UBS and WestLB AG.

 

 
 
   

 

Search our litigation database (Member's Only)

 

 
   


May 2012 Investors Notes
Limits on Playing the STOLI Card: A Carrier’s Duty to Investigate Fraud

November 2011 Investors Notes
Insurable Interest after Price Dawe, Schlanger and Brasner

June 2011 Investors Notes
Trends in Cost of Insurance

May 2011 Investors Notes
ILMA Releases Investors Note On Court Of of Appeals Ruling

January 2011 Investors Notes
As the Dust Settles in the Life Settlement Industry: A Review of Major Legal Decisions in 2010 and What's in Store for 2011

July 2010 Investors Notes
What Will the New Financial Reform Law Mean to the Longevity Markets?

June 2010 Investors Notes
Servicing of Life Settlements: A Critical Element for the Investor’s Consideration

January 2010 Investors Notes
Life Expectancy Underwriting

 

 

     
     


Copyright © 2007-2011, Institutional Lifemarkets Association | 925 15th Street, NW, Suite 500 | Washington, DC 20005